Search

Your search keyword '"Sharaf, Barry"' showing total 449 results

Search Constraints

Start Over You searched for: Author "Sharaf, Barry" Remove constraint Author: "Sharaf, Barry"
449 results on '"Sharaf, Barry"'

Search Results

51. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial)

54. OUTCOMES FOLLOWING URGENT/EMERGENT TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE STS/ACC TVT REGISTRY

56. Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study

57. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement

58. Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)

62. Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)

63. Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)

64. Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE)

66. In Women with Symptoms of Cardiac Ischemia, Non-Obstructive Coronary Arteries, and Microvascular Dysfunction, ACE Inhibition is Associated with Improved Microvascular Function: A Double-blind Randomized Study from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE): ACE-I Improves Microvascular Function in Women

67. Bio-informatics assessment schema (BIAS) to improve myocardial perfusion image diagnostic and prognostic value: the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study

68. TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

69. Bio-informatics assessment schema (BIAS) to improve myocardial perfusion image diagnostic and prognostic value: the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study

70. Does expanded artificial intelligence improve the prognostic value of myocardial perfusion imaging? A report from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)

71. Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study

73. DIFFERENTIAL EFFECTS OF COLD PRESSOR AND ACETYLCHOLINE DURING ENDOTHELIAL FUNCTION ASSESSMENT IN WOMEN WITH NO OBSTRUCTIVE CORONARY ARTERY DISEASE: THE NHLBI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY

74. Abstract 17055: A New Cohort Confirms the High Prevalence and Severity of Endothelial and Microvascular Dysfunction Among Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)

75. Timing of hormone therapy, type of menopause, and coronary disease in women

77. RELATIONSHIP BETWEEN CORONARY MICRO- AND MACROVASCULAR MEASURES IN WOMEN WITH CHEST PAIN WITHOUT SIGNIFICANT CORONARY ARTERY DISEASE: AN ANCILLARY SUBSTUDY FROM THE NHBLI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE)

78. Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study

79. Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study

80. Prognostic Value of Global MR Myocardial Perfusion Imaging in Women With Suspected Myocardial Ischemia and No Obstructive Coronary Disease

82. IN WOMEN WITH SYMPTOMS OF CARDIAC ISCHEMIA, NONOBSTRUCTIVE CORONARY ARTERIES AND MICROVASCULAR DYSFUNCTION, ACE INHIBITION IS ASSOCIATED WITH IMPROVED MICROVASCULAR FUNCTION: A DOUBLE-BLIND RANDOMIZED ANCILLARY STUDY FROM THE NHLBI WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE)

83. CONSTRICTION OF THE BRACHIAL ARTERY DURING BRACHIAL ARTERY REACTIVITY TESTING PREDICTS MAJOR ADVERSE CLINICAL OUTCOMES IN WOMEN WITH SUSPECTED MYOCARDIAL ISCHEMIA: THE NHLBI-SPONSORED WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY

84. Total Estrogen Time and Obstructive Coronary Disease in Women: Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

85. Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation

86. Importance of Socioeconomic Status as a Predictor of Cardiovascular Outcome and Costs of Care in Women with Suspected Myocardial Ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

87. Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation

88. Abstract 2450: A Randomized Controlled Trial of Low Dose Hormone Therapy on Myocardial Ischemia in Postmenopausal Women with No Obstructive Coronary Artery Disease:Results from the NHLBI-sponsored WISE

89. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)

90. The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease

91. Phytoestrogens and Lipoproteins in Women

92. Depression Is Associated With Cardiac Symptoms, Mortality Risk, and Hospitalization Among Women With Suspected Coronary Disease: The NHLBI-Sponsored WISE Study

93. Impaired Coronary Vascular Reactivity and Functional Capacity in Women

94. Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study

95. Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study

96. Electrocardiographic Predictors of Cardiovascular Outcome in Women

97. Social Networks Are Associated With Lower Mortality Rates Among Women With Suspected Coronary Disease: The National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation Study

98. Determination of Menopausal Status in Women: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study

99. Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease

100. 801-1 In women with symptoms of ischemic heart disease, global and regional myocardial perfusion status by magnetic resonance imaging better assigns risk: Results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)

Catalog

Books, media, physical & digital resources